MMQ, being an orphan drug the likely onto market would be 12 to 18 months after completion of phase 11B. Going it alone if 11B gives a good result would in all likelyhood be a more long term profitibility for ANP. Most pharma's look to a substantial payment at phase 11 plus royalty payments on market completion, where as alone would be 100% of profit until 2034. A successful 11B should mean a farely large increase in SP.
should create some interest, page-8
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
